FRANCISCO JAVIER
GRANDAS PÉREZ
Profesor titular de universidad
Technical University Munich
Múnich, AlemaniaTechnical University Munich-ko ikertzaileekin lankidetzan egindako argitalpenak (1)
2021
-
Safety and efficacy of tilavonemab in progressive supranuclear palsy: a phase 2, randomised, placebo-controlled trial
The Lancet Neurology, Vol. 20, Núm. 3, pp. 182-192